Skip to main content
Clinical Trials/NCT05710614
NCT05710614
Completed
Not Applicable

Mixed Plant- vs. Animal-based Supplementary Protein to Support Muscle Adaptations to Resistance Exercise: a Randomized Clinical Trial

University of Sao Paulo General Hospital1 site in 1 country40 target enrollmentAugust 1, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Dietary Supplements
Sponsor
University of Sao Paulo General Hospital
Enrollment
40
Locations
1
Primary Endpoint
vastus lateralis muscle cross sectional area
Status
Completed
Last Updated
last year

Overview

Brief Summary

This is a randomized controlled trial aimed to investigate the effects of different supplementary protein sources on muscle adaptations to resistance exercise. Young, healthy, recreationally active participants consuming an omnivorous diet with protein intake within recommended dietary allowance (RDA) (i.e.; 0.8-1.0 g.kg-1. d-1) will be recruited to undergo a 12-wk supervised resistance training program in combination with the intake of three 15-g daily doses (45g. d-1 total) of either a mixed plant- (i.e.; soy and pea protein) or animal-based (i.e.; whey protein) protein in drink form as a supplementary source of protein to their main meals of the day (i.e.; breakfast, lunch, and dinner). Before (PRE) and after (POST) the 12-wk intervention, participants will be assessed for body composition by dual-energy X-ray absorptiometry (DXA), muscle cross-sectional area (ultrasound) and fiber cross-sectional area (muscle biopsy), and maximal isotonic strength (1RM). Training consists of a resistance training (RT) program individually supervised by a researcher blinded to treatment in a laboratorial setting. Assessments will also be conducted in a blinded fashion.

Registry
clinicaltrials.gov
Start Date
August 1, 2023
End Date
November 27, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
Male

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Hamilton Augusto Roschel da Silva

Doctor of Philosophy

University of Sao Paulo General Hospital

Eligibility Criteria

Inclusion Criteria

  • Physically active (according to the International Physical Activity Questionnaire (IPAQ)
  • Absence of any chronic condition that could preclude participation in a RT program or physical testing
  • Habitual protein consumption within RDA ≥ 0.8 ≤1.0 g.kg-

Exclusion Criteria

  • Prior history of anabolic steroids use, current or previous (≤ 3 m)
  • Use of ergogenic or protein-based supplements, current or previous (\< 1 y)
  • Engagement in energy-restricted diets

Outcomes

Primary Outcomes

vastus lateralis muscle cross sectional area

Time Frame: Ultrasound images will be obtained both at baseline (before the comencement of the study) and immediately after the 12-week intervention period

the investigators used ultrasound measures of the vastus lateralis cross sectional area as the primary outcome

Secondary Outcomes

  • lean mass(DXA scans will be taken both at baseline (before the comencement of the study) and immediately after the 12-week intervention period)
  • fiber cross sectional area(Fiber cross sectional areas will be measured both at baseline (before the comencement of the study) and immediately after the 12-week intervention period)
  • maximal isotonic strength(1-RM tests will be taken both at baseline (before the comencement of the study) and immediately after the 12-week intervention period)

Study Sites (1)

Loading locations...

Similar Trials